Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-24T20:34:47.162Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment-Refractory Schizoaffective Disorder in a Patient with Dyke-Davidoff-Masson Syndrome

Published online by Cambridge University Press:  07 November 2014

Benedikt Amann ,
Celia García de la Iglesia ,
Peter McKenna ,
Edith Pomarol-Clotet ,
Marisa Sanchez-Guerra  and
Michael Orth
Get access Rights & Permissions [Opens in a new window]

Abstract

Dyke-Davidoff-Masson syndrome, or cerebral hemiatrophy, is a pre- or perinatally acquired entity characterized by predominantly neurologic symptoms, such as seizures, facial asymmetry, contralateral hemiplegia, and mental retardation. Psychiatric symptoms are rarely reported. We report the first case of left cerebral hemiatrophy and a late onset of treatment-resistant schizoaffective disorder after a stressful life event. The patient finally responded well to clozapine. The clinical history and results from structural neuroimaging are highlighted to discuss the possible developmental bias for psychotic disorders.

Type
Case Report
Information
CNS Spectrums , Volume 14 , Issue 1 , January 2009 , pp. 36 - 40
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Harrison, PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain. 1999;122(pt 4):593–624.CrossRefGoogle ScholarPubMed
2.Cannon, TD, van Erp, TG, Rosso, IM, et al.Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry. 2002;59:35–41.Google Scholar
3.Zeiss, J, Brinker, RA. MR imaging of cerebral hemiatrophy. J Comput Assist Tomogr. 1988;12:640–643.Google Scholar
4.Puri, BK, Hall, AD, Lewis, SW. Cerebral hemiatrophy and schizophrenia. Br J Psychiatry. 1994;165:403–405.Google Scholar
5.Honer, WG, Bassett, AS, Falkai, P, et al.A case study of temporal lobe development in familial schizophrenia. Psychol Med. 1996;26:191–195.Google Scholar
6.Lyketsos, CG, Kozauer, N, Rabins, PV. Psychiatric manifestations of neurologic disease: where are we headed? Dialogues Clin Neurosci. 2007;9:111–124.CrossRefGoogle ScholarPubMed
7.Amann, B, Sterr, A, Thoma, H, et al.Psychopathological changes preceding motor symptoms in Huntington's disease: a report on four cases. World J Biol Psychiatry. 2000;1:55–58.CrossRefGoogle ScholarPubMed
8.Getz, GE, DelBello, MP, Fleck, DE, et al.Neuroanatomic characterization of schizoaffective disorder using MRI: a pilot study. Schizophr Res. 2002;55:55–59.Google Scholar
9.Lewine, RR, Hudgins, P, Brown, F, et al.Differences in qualitative brain morphology findings in schizophrenia, major depression, bipolar disorder, and normal volunteers. Schizophr Res. 1995;15:253–259.CrossRefGoogle ScholarPubMed
10.Delisi, LE. The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia. Schizophr Bull. 2008;34:312–321.CrossRefGoogle ScholarPubMed
11.Rotarska-Jagiela, A, Schönmeyer, R, Oertel, V, Haenschel, C, Vogeley, K, Linden, DE. The corpus callosum in schizophrenia-volume and connectivity changes affect specific regions. Neuroimage. 2008;39:1522–1532.Google Scholar
12.Nuechterlein, KH, Dawson, ME. A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull. 1984;10:300–312.CrossRefGoogle ScholarPubMed
13.Bruder, GE, Stewart, JW, Towey, JP, et al.Abnormal cerebral laterality in bipolar depression: convergence of behavioral and brain event-related potential findings. Biol Psychiatry. 1992;32:33–47.Google Scholar
14.Morris, PL, Robinson, RG, Raphael, B, et al.Lesion location and poststroke depression. J Neuropsychiatry Clin Neurosci. 1996;8:399–403.Google ScholarPubMed